专利名称:ANTAGONISTS, USES & METHODS FOR
PARTIALLY INHIBITING TNFR1
发明人:STOOP, Adriaan Allart申请号:EP10737010.8申请日:20100714公开号:EP2453920A2公开日:20120523
摘要:The present invention relates to anti-Tumor Necrosis Factor 1 (TNFR1, p55,CD120a, P60, TNF receptor superfamily member 1A, TNFRSF1A) antagonists for partiallyinhibiting TNFR1 useful for the treatment and/or prevention of TNFR1- mediateddiseases or conditions such as arthritis, psoriasis, Crohn's disease, COPD, lunginflammatory conditions and asthma. The invention further relates to methods, uses,formulations, compositions and devices comprising or using such anti-TNFR1 antagonists.
申请人:Glaxo Group Limited
地址:Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN GB
国籍:GB
代理机构:Sayce, Alastair George
更多信息请下载全文后查看
因篇幅问题不能全部显示,请点此查看更多更全内容
Copyright © 2019-2025 efsc.cn 版权所有 赣ICP备2024042792号-1
违法及侵权请联系:TEL:199 1889 7713 E-MAIL:2724546146@qq.com
本站由北京市万商天勤律师事务所王兴未律师提供法律服务